Trade PLRZ anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Polyrizon Ltd. (PLRZ) is trading at US$12.54, down 2.01% today as of Aug 28, 12:18 EDT. The company has a market capitalisation of US$21.46M. Over the past 52 weeks, PLRZ has traded between US$0.53 and US$18.20. On Syfe you can trade PLRZ with $0 commission and add it to your watchlist.
| Previous close | US$12.80 |
|---|---|
| Market cap | US$21.46M |
| 52-week range | US$0.53 – US$18.20 |
| Volume | 23.98K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Polyrizon Ltd.
Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel.
Year: 2024
Polyrizon Says Nasarix Allergy Nasal Spray Meets All Biocompatibility Safety Standards in Testing
Jul 2, 1:06 PM · MT Newswires
Polyrizon Receives Approval for Human Trial of Nasarix Nasal Spray for Allergic Rhinitis
Jun 29, 1:46 PM · MT Newswires
Polyrizon Signs Agreements for Nasarix Human Study
Jun 15, 12:46 PM · MT Newswires
Polyrizon Advances Nasarix Study With 3 Major US Trial Sites
Jun 8, 1:51 PM · MT Newswires
Polyrizon Closes $3.5 Million Registered Direct and Private Placements
Apr 8, 9:17 PM · MT Newswires
Polyrizon Ltd. (PLRZ) stock is trading at US$12.54, -2.01% from the previous close of US$12.80.
The market cap for Polyrizon Ltd. (PLRZ) stock is approximately US$21.46M.
The 52-week high for Polyrizon Ltd. (PLRZ) stock is US$18.20.
The 52-week low for Polyrizon Ltd. (PLRZ) stock is US$0.53.
Polyrizon Ltd. (PLRZ) does not currently pay a dividend.
Stay on top of PLRZ
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
